Skip to main content

Newsroom Search

Search the Newsroom

Filter By

Related specialties and programs

Showing 61 - 70 of 2779 results

News

Children’s Hospital of Philadelphia Researchers Find Promising Preclinical Results for High-Risk Neuroblastoma

Researchers at Children’s Hospital of Philadelphia (CHOP) demonstrated a promising new approach in the fight against high-risk neuroblastoma, a common and potentially deadly childhood cancer that can occur within the peripheral nervous system. The study, recently published in Nature Communications, found that chimeric antigen receptor (CAR) T-cell therapy targeting two markers on neuroblastoma cancer cells simultaneously boosted overall immune response by engaging adaptive and innate immunity in preclinical models.

Young girl studying drinking an energy drink
News

Researchers at Children’s Hospital of Philadelphia Advocate for Energy Drink Regulation

Energy drinks, marketed for boosting energy, concentration, and athletic performance, can pose significant cardiovascular risks, including death. Despite the American Academy of Pediatrics’ advice against caffeine consumption by children and adolescents, the United States remains the least regulated country and should take immediate steps to protect vulnerable populations, leading cardiology researchers at Children’s Hospital of Philadelphia (CHOP) urged in a recent commentary in the Journal of Pediatrics.

Jump back to top